Method and device for bioassays
A method and device for multiplexing and calibrating rapid quantification of biomolecules present in a nanofluidic biosensor composed by a nanoslit. A novel concept defining multiple different local structured areas containing biomarkers. Local structured areas can also be structured to decrease the biomarkers density in the nanoslit. Such enables the multiplexed quantification biomolecular interactions of interest in the same nanofluidic biosensor.
1. A biosensor for detecting and quantifying fluorescently-labeled biomolecules, said biosensor comprising:
a lower substrate;
an upper substrate stacked on said lower substrate;
a nanoslit which is a microfabricated structure with one-nanometer-sized dimension, formed between said lower substrate and said upper substrate, said nanoslit comprising a plurality of local structured areas disposed along said nanoslit;
a lateral input aperture in direct contact with said nanoslit, for letting a solution containing biomolecules enter said nanoslit; and
a lateral output aperture in direct contact with said nanoslit, for driving said solution through said nanoslit, wherein the plurality of local structured areas are each functionalized by different biomarkers.
2. Biosensor according to claim 1 wherein said biologically or chemically interact with specific biomolecules contained in said solution.
3. Biosensor according to claim 1 , wherein said plurality of biomarkers do not interact biologically or chemically with non-specific biomolecules contained in said solution.
4. Biosensor according to claim 1 , wherein said lower and upper substrates are made of a material selected from the group comprising silicon, glass, plastic and oxide compounds.
5. Biosensor according to claim 1 , wherein said lateral input aperture and said lateral output aperture each have an area from 100 nm 2 to 20 mm 2 and said nanoslit has at least one dimension between 2 nm and 1000 nm.
6. Biosensor according to claim 1 wherein the plurality of functionalized areas differ from each other in that they are functionalized by different types of biomarkers.
7. Biosensor according to claim 1 wherein the plurality of functionalized areas differ from each other in that they are functionalized by different densities of biomarkers.
8. An array comprising a plurality of biosensors according to claim 1 , said biosensors being in a fixed position relative to each other inside a system.
9. Assembly comprising at least one biosensor according to claim 1 , and further comprising optical means for fluorescence excitation and detection.
10. Assembly according to claim 9 , wherein said optical means is a fluorescence measurement unit comprising a single-photon detector.
11. Assembly according to claim 9 , wherein said single-photon detector is a CMOS or CCD detector array.
12. Assembly according to claim 9 , wherein said single-photon detector is an avalanche photodiode (APD).
13. Assembly according to claim 9 , wherein said single-photon detector is a photomultiplier tube (PMT).
14. A method for detecting and quantifying the presence of fluorescently-labeled biomolecules in a solution, said method comprising the steps of:
a) providing at least one biosensor according to claim 1 ;
b) filling said at least one biosensor with an aqueous solution, from a lateral input aperture of said at least one biosensor, across a nanoslit of said at least one biosensor, towards a lateral output aperture of said at least one biosensor, by depositing said aqueous solution into said lateral input aperture, wherein said aqueous solution contains fluorescently-labeled biomolecules that can be specific to a plurality of biomarkers immobilized on a plurality of local structured areas of said nanoslit;
c) detecting specific complexes made of fluorescently-labelled biomolecules immobilized on said plurality of biomarkers inside said nanoslit by measuring with an optical system the fluorescence intensity of fluorophores attached to said specific complexes, wherein said plurality of local structured areas are patterned for immobilizing different biomarkers, and
d) quantifying the presence of fluorescently-labelled biomolecules in the solution based on the fluorescence intensity measured with the optical system.
15. Method according to claim 14 , wherein said fluorescently-labeled biomolecules are proteins, DNA, RNA, antibodies, amino acids, nucleic acids, enzymes, lipid molecules, peptides, polysaccharides and/or viruses.